Acutaas Chemicals shares rose as much as 12% after September-quarter revenue increased 43% year on year and EBITDA climbed 86%. The company raised FY27 revenue growth guidance to about 30% and EBITDA margin guidance to 38–40%, citing strong visibility and orders.